根據最新的財務報表(Form-10K),Carl Zeiss Meditec AG 的總資產為 $0,淨isProfitable}為 $0
CZMWF 的關鍵財務比率是什麼?
Carl Zeiss Meditec AG 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Carl Zeiss Meditec AG 的收入按細分市場或地理位置如何劃分?
Carl Zeiss Meditec AG 最大收入來源為 Ophthalmology,在最近的收益報告中收入為 1,723,707,000。就地區而言,EMEA 是 Carl Zeiss Meditec AG 的主要市場,收入為 657,500,000。
Carl Zeiss Meditec AG 是否盈利?
無,根據最新的財務報表,Carl Zeiss Meditec AG 的淨損失為 $0
Carl Zeiss Meditec AG 有負債嗎?
無,Carl Zeiss Meditec AG 的負債為 0
Carl Zeiss Meditec AG 的流通股有多少?
Carl Zeiss Meditec AG 的總流通股為 0
關鍵數據
前收市價
$34.71
開盤價
$32.76
當日範圍
$32.76 - $32.76
52週區間
-
交易量
150
平均成交量
--
股息收益率
--
每股盈餘 (TTM)
--
市值
--
什麼是 Carl Zeiss Meditec AG?
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.